ROSALIND BLAIR: Open Payments
NPI 1710224795 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| TerSera Therapeutics LLC | 4 | $109 |
| Nalu Medical, Inc. | 1 | $62 |
| SPR Therapeutics, Inc | 1 | $22 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| AppliedVR Inc | 1 | $18 |
| Averitas Pharma Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Prialt, Nalu Neurostimulation System, SPRINT PNS System, XTAMPZA, RelieVRx, QUTENZA, RELISTOR.
Industry payments across PA — which companies pay providers there.
